Awards from 2016

Kellison Distinguished Service Award

Each year, the Kellison Distinguished Service Award is presented to an individual who, over an extended period of time, has served the diagnostic laboratory industry in an outstanding way, especially through his or her organizational leadership, effective management and/or valuable non-profit service to the industry.

Gregory S. Henderson, M.D., Ph.D., was awarded the 2016 G2 Laboratory Public Service Distinguished Leadership Award, sponsored by Kellison & Company, a revenue cycle management solutions company. Kellison’s Chief Executive Officer Scott Liff presented the award at G2’s 34th Annual Lab institute Conference at the Hyatt Regency Capitol Hill, Washington, D.C. on Thursday, Oct. 27, 2016.

For almost a decade, Kellison has sponsored this annual award, presented to a diagnostic laboratory industry executive exemplifying the traits of leadership, excellence, and service to the industry. The award recognizes contributions to enhancing patient care and the laboratory profession through business management, research, public policy or service and innovation.

Dr. Henderson was named President of BioReference Laboratories, a division of OPKO Health, Inc. in March 2016. He has served as a leader in pathology and laboratory medicine as a pathologist, executive and innovator. He has guided business growth and operations of one of the largest laboratory outreach programs in the United States, served on a team charged with rebuilding healthcare infrastructure in New Orleans after Hurricane Katrina, co-developed the first cloud based anatomic pathology information system, and founded a company that leverages cloud technology solutions to provide digital pathology consultations that afford access to quality diagnostics in the developed and developing world.

The Annual Halfpenny Lab Innovation Award

Each year, Halfpenny partners with G2 Intelligence to seek out and recognize an industry leader for his or her innovation in the lab industry.  We wish to celebrate that leader who has matched new challenges with new ideas, tossing aside the sacred cows and failed strategies, and produced measurable and tangible results!

Dr. Frank Cockerill, Chief Executive Officer of Analyte Health, received G2 Intelligence’s Lab Innovation Award, designed to recognize innovation in the field of diagnostics. The award, sponsored by Halfpenny Technologies Inc., was presented by Jack Redding, senior vice president, sales and marketing, for Halfpenny, on Friday, Oct. 28 at Lab Institute in Washington, D.C. Cockerill was recognized for his leadership of Analyte Health in innovating patient access to diagnostic testing. As CEO, Cockerill is leading Analyte Health in pioneering online diagnostic services aimed directly to consumers—including education, diagnostic testing, personalized results and recommendations about next steps. Similarly, award sponsor Halfpenny also strives to improve access to diagnostic test results with its interoperability solutions that enable clinical data exchange through secure, scalable, cloud-based, vendor neutral clinical data exchange platforms.

Cockerill previously led the Department of Laboratory Medicine and Pathology at Mayo Clinic and was Chief Executive Officer of Mayo Medical Laboratories, a global reference laboratory operating within Mayo Clinic. He was also the Ann and Leo Markin Professor of Microbiology and Medicine at the Mayo Clinic College of Medicine, having extensive experience and expertise in infectious diseases and antimicrobial resistance.